ESTHER CAHN: Open Payments
NPI 1023893815 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,517 in 76 payments from 24 companies in 2025. Trend: 2023 $113 · 2024 $949 · 2025 $1,517
Food & beverage: $1,418Education: $99
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $231 |
| Novo Nordisk Inc | 20 | $182 |
| ABBVIE INC. | 7 | $179 |
| GENZYME CORPORATION | 1 | $113 |
| Corcept Therapeutics | 5 | $100 |
| Eli Lilly and Company | 1 | $99 |
| Amgen Inc. | 4 | $67 |
| Exact Sciences Corporation | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $53 |
| Globus Medical, Inc. | 2 | $47 |
Products named: Kerendia, Ozempic, QULIPTA, FABRAZYME, Korlym, Cologuard Collection Kit, XIFAXAN, Senza.
Industry payments across MD — which companies pay providers there.
